Pharmacovigilance and Drug Safety

Pharmacovigilance is the most essential issue as it shapes the establishment of the structure of well-being. As indicated by WHO, PV is characterized as the science and exercises identifying with the recognition, appraisal, comprehension, and avoidance of unfriendly impacts or some other medication-related issue. Adverse drug reaction (ADR) reporting in PV is an essential measure of flag recognition, notwithstanding being exceedingly cost effective. Moreover, it is intense as the strategy for identifying wellbeing worries in connection to medications and it assumes an essential part in PV. Consequently, ADR reporting is the frontline defense system to ensure drug safety.  Michiko Yamamoto, The Part of a Drug specialist and Undergrad Drug store Training with Exceptional Reference to the Unfriendly Medication Response Revealing Framework in Japan.

 

  • Adverse Drug Reactions
  • Pharmacovigilance and Risk Management
  • Pharmacy Practices and its Challenges
  • Biopharmaceutical Sciences
  • Clinical Trials on Various Disorders

Related Conference of Pharmacovigilance and Drug Safety

February 25-26, 2026

16th International Conference on Chemistry Meeting

Paris, France
February 26-27, 2026

29th World Congress on Materials Chemistry

Paris, France
June 17-18, 2026

15th World Congress on Chromatography

Paris, France
August 11-12, 2026

5th World Congress on Plasma Chemistry and Plasma Processing

Amsterdam, Netherlands
September 14-15, 2026

22nd European Organic Chemistry Congress

Rome, Italy
September 21-22, 2026

16th International Chemistry Congress

Barcelona, Spain
November 26-27, 2026

6th International Conference on Petrochemistry and Natural Gas

Amsterdam, Netherlands

Pharmacovigilance and Drug Safety Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in